InsiderClue
Stocks · Health care · Pharmaceutical Preparations

CORCEPT THERAPEUTICS INC

CORT Clue Score62
United States Fiscal year ends December CIK 0001088856
$121.19 +2.24% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $121.19 +482.08% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue81.3Operating income10.2Net income8.1EPS, diluted0.07Fiscal year 2017Revenue159.2 +95.8%Operating income52.9Net income129.1 +1,486.3%EPS, diluted1.04 +1,385.7%Fiscal year 2018Revenue251.2 +57.8%Operating income89.5Net income75.4 −41.6%EPS, diluted0.60 −42.3%Fiscal year 2019Revenue306.5 +22.0%Operating income111.6Net income94.2 +24.9%EPS, diluted0.77 +28.3%Fiscal year 2020Revenue353.9 +15.5%Operating income128.2Net income106.0 +12.6%EPS, diluted0.85 +10.4%Fiscal year 2021Revenue366.0 +3.4%Operating income124.5Net income112.5 +6.1%EPS, diluted0.89 +4.7%Fiscal year 2022Revenue401.9 +9.8%Operating income112.6Net income101.4 −9.9%EPS, diluted0.87 −2.2%Fiscal year 2023Revenue482.4 +20.0%Operating income107.3Net income106.1 +4.7%EPS, diluted0.94 +8.0%Fiscal year 2024Revenue675.0 +39.9%Operating income137.0Net income141.2 +33.0%EPS, diluted1.23 +30.9%Fiscal year 2025Revenue761.4 +12.8%Operating income44.8Net income99.7 −29.4%EPS, diluted0.82 −33.3%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 81.3 159.2 251.2 306.5 353.9 366.0 401.9 482.4 675.0 761.4
Growth +95.8% +57.8% +22.0% +15.5% +3.4% +9.8% +20.0% +39.9% +12.8%
Operating income 10.2 52.9 89.5 111.6 128.2 124.5 112.6 107.3 137.0 44.8
Net income 8.1 129.1 75.4 94.2 106.0 112.5 101.4 106.1 141.2 99.7
Growth +1,486.3% −41.6% +24.9% +12.6% +6.1% −9.9% +4.7% +33.0% −29.4%
EPS, diluted 0.07 1.04 0.60 0.77 0.85 0.89 0.87 0.94 1.23 0.82
Growth +1,385.7% −42.3% +28.3% +10.4% +4.7% −2.2% +8.0% +30.9% −33.3%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin12.5%Net margin10.0%Free cash flow margin22.4%Fiscal year 2017Operating margin33.2%Net margin81.1%Free cash flow margin38.0%Fiscal year 2018Operating margin35.6%Net margin30.0%Free cash flow margin45.9%Fiscal year 2019Operating margin36.4%Net margin30.7%Free cash flow margin44.1%Fiscal year 2020Operating margin36.2%Net margin30.0%Free cash flow margin42.6%Fiscal year 2021Operating margin34.0%Net margin30.7%Free cash flow margin45.7%Fiscal year 2022Operating margin28.0%Net margin25.2%Free cash flow margin29.8%Fiscal year 2023Operating margin22.2%Net margin22.0%Free cash flow margin26.2%Fiscal year 2024Operating margin20.3%Net margin20.9%Free cash flow margin29.1%Fiscal year 2025Operating margin5.9%Net margin13.1%Free cash flow margin18.6%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 12.5% 33.2% 35.6% 36.4% 36.2% 34.0% 28.0% 22.2% 20.3% 5.9%
Net margin 10.0% 81.1% 30.0% 30.7% 30.0% 30.7% 25.2% 22.0% 20.9% 13.1%
Free cash flow margin 22.4% 38.0% 45.9% 44.1% 42.6% 45.7% 29.8% 26.2% 29.1% 18.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow18.4Capital expenditure−0.2Free cash flow18.2Buybacks0.0Fiscal year 2017Operating cash flow60.9Capital expenditure−0.4Free cash flow60.5 +232.6%Buybacks0.0Fiscal year 2018Operating cash flow115.7Capital expenditure−0.3Free cash flow115.4 +90.6%Buybacks−23.7Fiscal year 2019Operating cash flow136.1Capital expenditure−1.1Free cash flow135.0 +17.0%Buybacks−31.0Fiscal year 2020Operating cash flow152.0Capital expenditure−1.2Free cash flow150.7 +11.6%Buybacks−9.9Fiscal year 2021Operating cash flow167.9Capital expenditure−0.5Free cash flow167.4 +11.1%Fiscal year 2022Operating cash flow120.3Capital expenditure−0.4Free cash flow119.9 −28.4%Buybacks0.0Fiscal year 2023Operating cash flow126.7Capital expenditure−0.1Free cash flow126.5 +5.5%Buybacks0.0Fiscal year 2024Operating cash flow198.3Capital expenditure−2.2Free cash flow196.1 +55.0%Buybacks−15.7Fiscal year 2025Operating cash flow142.0Capital expenditure−0.2Free cash flow141.8 −27.7%Buybacks−172.9
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 18.4 60.9 115.7 136.1 152.0 167.9 120.3 126.7 198.3 142.0
Capital expenditure −0.2 −0.4 −0.3 −1.1 −1.2 −0.5 −0.4 −0.1 −2.2 −0.2
Free cash flow 18.2 60.5 115.4 135.0 150.7 167.4 119.9 126.5 196.1 141.8
Growth +232.6% +90.6% +17.0% +11.6% +11.1% −28.4% +5.5% +55.0% −27.7%
Buybacks 0.0 0.0 −23.7 −31.0 −9.9 n/a 0.0 0.0 −15.7 −172.9

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash51.5Total debt14.7Net cash (debt)36.9Shareholders’ equity41.4Debt to equity0.35Fiscal year 2017Cash31.1Total debt0.0Net cash (debt)31.1Shareholders’ equity191.0Debt to equity0.00Fiscal year 2018Cash41.6Shareholders’ equity275.9Fiscal year 2019Cash31.3Shareholders’ equity371.2Fiscal year 2020Cash76.2Shareholders’ equity523.3Fiscal year 2021Cash77.6Shareholders’ equity375.8Fiscal year 2022Cash66.3Shareholders’ equity501.8Fiscal year 2023Cash135.6Shareholders’ equity506.7Fiscal year 2024Cash127.7Shareholders’ equity679.6Fiscal year 2025Cash120.5Shareholders’ equity647.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 51.5 31.1 41.6 31.3 76.2 77.6 66.3 135.6 127.7 120.5
Total debt 14.7 0.0 n/a n/a n/a n/a n/a n/a n/a n/a
Net cash (debt) 36.9 31.1 n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders’ equity 41.4 191.0 275.9 371.2 523.3 375.8 501.8 506.7 679.6 647.8
Debt to equity 0.35 0.00 n/a n/a n/a n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
81.3 159.2 251.2 306.5 353.9 366.0 401.9 482.4 675.0 761.4
Growth +95.8% +57.8% +22.0% +15.5% +3.4% +9.8% +20.0% +39.9% +12.8%
2.1 3.6 5.2 5.5 5.6 5.3 5.4 6.5 10.9 13.0
23.8 40.4 75.2 89.0 114.8 113.9 131.0 184.4 246.9 254.9
45.2 62.4 81.3 100.4 105.3 122.4 152.8 184.3 280.3 448.7
10.2 52.9 89.5 111.6 128.2 124.5 112.6 107.3 137.0 44.8
Growth +419.3% +69.3% +24.7% +14.9% −2.9% −9.5% −4.8% +27.7% −67.3%
8.1 52.8 92.2 116.7 131.6 125.0 116.2 124.6 161.5 66.5
0.0 −76.3 16.7 22.5 25.6 12.5 14.8 18.4 20.3 −33.2
8.1 129.1 75.4 94.2 106.0 112.5 101.4 106.1 141.2 99.7
Growth +1,486.3% −41.6% +24.9% +12.6% +6.1% −9.9% +4.7% +33.0% −29.4%
Per share
0.07 1.14 0.65 0.82 0.92 0.97 0.95 1.02 1.35 0.95
0.07 1.04 0.60 0.77 0.85 0.89 0.87 0.94 1.23 0.82
Growth +1,385.7% −42.3% +28.3% +10.4% +4.7% −2.2% +8.0% +30.9% −33.3%
110.6 113.5 115.3 114.3 115.4 115.7 106.8 103.6 103.2 103.9
116.1 124.5 126.7 122.6 124.2 126.0 116.0 111.7 113.5 120.0
Growth +7.2% +1.7% −3.3% +1.3% +1.4% −7.9% −3.6% +1.6% +5.7%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 16.6% a year over five years, and earnings per share fell 0.7% a year.
  • The diluted share count fell 3.4% in five years, so buybacks did some of the work per share.
  • Operating margin is down 30.3 points on five years ago, at 5.9%.
  • Profitable in every one of the 10 years on file.